We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is HealthEquity (HQY) Down 11.5% Since Last Earnings Report?
Read MoreHide Full Article
It has been about a month since the last earnings report for HealthEquity (HQY - Free Report) . Shares have lost about 11.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is HealthEquity due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
HealthEquity Q2 Earnings and Revenues Beat Estimates
HealthEquity, Inc reported adjusted earnings per share of 42 cents in second-quarter fiscal 2021, which beat the Zacks Consensus Estimate of 27 cents by 55.6%. The bottom line fell 4.5% on a year-over-year basis.
Revenues in Detail
The company generated revenues of $176 million, beating the Zacks Consensus Estimate by 2.7%. However, the figure skyrocketed 103% from the prior-year quarter.
HSA Member Detail
As of Jul 31, 2020, the total number of Health Savings Accounts (HSA), for which HealthEquity served as a non-bank custodian (HSA members), was 5.4 million, up 29% year over year.
Additionally, total Active HSA assets were $12.2 billion, up 43% year over year.
Total Accounts, including HSAs and complementary CDB accounts, came in at 12.5 million, up 158% year over year.
Segmental Performance
Service Revenues: At this segment, revenues totaled $103.8 million, up 294.7% from the year-ago figure.
Custodial Revenues: At this segment, revenues grew 7.6% year over year to $46.9 million.
Interchange Revenues: At this segment, revenues soared 51.4% year over year to $25.3 million.
Margin Details
HealthEquity generated gross profit of $101.8million, up 74.2% from the year-ago quarter. Gross margin was 57.8% of net revenues, down 965basis points (bps) year over year.
Adjusted operating profit in the fiscal second quarter was $50.6 million, up 34.9% year over year. Adjusted operating margin totaled 28.8% in the quarter, contracting 1456 bps year over year.
Financial Position
The company exited the fiscal second quarter with cash and cash equivalents of $268.9 million, compared with $720.8 million at the end of the fiscal first quarter.
Cumulative cash flow from operating activities in the second quarter came in at $68.7 million, up from $56.8 million in the year-ago period.
2021 Guidance
For fiscal 2021, revenues are projected within $720 million and $730 million. The Zacks Consensus Estimate for the same is pegged at $738.6 million.
Adjusted earnings per share are expected within $1.48 and $1.58. The Zacks Consensus Estimate for the same is pegged at $1.44.
How Have Estimates Been Moving Since Then?
It turns out, fresh estimates flatlined during the past month. The consensus estimate has shifted 18.7% due to these changes.
VGM Scores
Currently, HealthEquity has an average Growth Score of C, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
HealthEquity has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is HealthEquity (HQY) Down 11.5% Since Last Earnings Report?
It has been about a month since the last earnings report for HealthEquity (HQY - Free Report) . Shares have lost about 11.5% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is HealthEquity due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
HealthEquity Q2 Earnings and Revenues Beat Estimates
HealthEquity, Inc reported adjusted earnings per share of 42 cents in second-quarter fiscal 2021, which beat the Zacks Consensus Estimate of 27 cents by 55.6%. The bottom line fell 4.5% on a year-over-year basis.
Revenues in Detail
The company generated revenues of $176 million, beating the Zacks Consensus Estimate by 2.7%. However, the figure skyrocketed 103% from the prior-year quarter.
HSA Member Detail
As of Jul 31, 2020, the total number of Health Savings Accounts (HSA), for which HealthEquity served as a non-bank custodian (HSA members), was 5.4 million, up 29% year over year.
Additionally, total Active HSA assets were $12.2 billion, up 43% year over year.
Total Accounts, including HSAs and complementary CDB accounts, came in at 12.5 million, up 158% year over year.
Segmental Performance
Service Revenues: At this segment, revenues totaled $103.8 million, up 294.7% from the year-ago figure.
Custodial Revenues: At this segment, revenues grew 7.6% year over year to $46.9 million.
Interchange Revenues: At this segment, revenues soared 51.4% year over year to $25.3 million.
Margin Details
HealthEquity generated gross profit of $101.8million, up 74.2% from the year-ago quarter. Gross margin was 57.8% of net revenues, down 965basis points (bps) year over year.
Adjusted operating profit in the fiscal second quarter was $50.6 million, up 34.9% year over year. Adjusted operating margin totaled 28.8% in the quarter, contracting 1456 bps year over year.
Financial Position
The company exited the fiscal second quarter with cash and cash equivalents of $268.9 million, compared with $720.8 million at the end of the fiscal first quarter.
Cumulative cash flow from operating activities in the second quarter came in at $68.7 million, up from $56.8 million in the year-ago period.
2021 Guidance
For fiscal 2021, revenues are projected within $720 million and $730 million. The Zacks Consensus Estimate for the same is pegged at $738.6 million.
Adjusted earnings per share are expected within $1.48 and $1.58. The Zacks Consensus Estimate for the same is pegged at $1.44.
How Have Estimates Been Moving Since Then?
It turns out, fresh estimates flatlined during the past month. The consensus estimate has shifted 18.7% due to these changes.
VGM Scores
Currently, HealthEquity has an average Growth Score of C, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
HealthEquity has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.